Skip to main content
. 2011 Oct 14;17(38):4321–4333. doi: 10.3748/wjg.v17.i38.4321

Figure 2.

Figure 2

Effect of lamivudine treatment vs control (placebo or no intervention) on interruption of hepatitis B virus mother-to-child transmission as indicated by newborn serum hepatitis B surface antigen or hepatitis B virus DNA. Vertical line indicates no difference between compared treatment. Horizontal lines show 95% CIs. Squares indicate point estimates, and the size of the squares indicates the weight of each study in the meta-analysis. HBeAg: Hepatitis B e antigen; HBsAg: Hepatitis B surface antigen; M-H random: Mantel-Haenszel random-effects model; CI: Confidence interval; HBV: Hepatitis B virus; RR: Risk ratio.